For example, when compared to prostate cancers from predominantly White men, prostate cancers from Black men contain fewer TMPRSS2-ERG fusions [19–22], fewer PTEN deletions [20–23], and more SPOP mutations [21,22]. This evidence concerns the gene PTEN and Familial prostate cancer.